Share the post "Shareholding Pattern: Shareholding Pattern Indrayani Biotech FY(Q1-Jun 2024-2025)"
Indrayani Biotech has released its latest shareholding reports, covering the quarter and the first half of the fiscal year ending on (Q1-Jun 2024-2024).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
Shareholder Name | Previous Quater Quantity(In Crores) | Current Quater Quantity(In Crores) | Previous Quater Shares(in %) | Current Quater Shares(in %) | Quater to Quater Difference |
---|---|---|---|---|---|
Promoters | 1.53 | 1.52 | 42.13 | 33.48 | -8.65 % |
Public | 2.10 | 3.03 | 49.4 | 59.73 | +10.33 % |
DII | 0.31 | 0.31 | 8.47 | 6.79 | -1.68 % |
FII | 0 | 0 | 0 | 0 | 0 |
Government | 0 | 0 | 0 | 0 | 0 |
Promoters’ shareholding decreased from 42.13% in March 2024 to 33.48% in June 2024. This reduction indicates that the promoters’ control over Company has weakened during this period.The percentage of shares held by the public increased from 49.4% in March 2024 to 59.73% in June 2024.This change suggests that the public’s investment in the company grew during the quarter.Domestic Institutional Investor’s (DII) shareholding decreased slightly from 8.47% in March 2024 to 6.79% in June 2024 , indicating that domestic institutions reduced their -1.68 stake in the company.
Let’s look into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.
Shareholder Name | Previous Quarter Quantity (In crores) | Current Quarter Quantity (In crores) | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
---|---|---|---|---|---|
G Swaminathan . | 0.414 | 0.414 | 11.41 | 9.09 | -2.32 % |
Sayee Sundar Kasiraman | 0.263 | 0.263 | 7.25 | 5.78 | -1.47 % |
I Umasundari . | 0.210 | 0.210 | 5.78 | 4.61 | -1.17 % |
S Indirakumar . | 0.210 | 0.210 | 5.78 | 4.61 | -1.17 % |
Jothi Ramesh . | 0.105 | 0.105 | 2.89 | 2.31 | -0.58 % |
M Ramesh . | 0.105 | 0.105 | 2.89 | 2.31 | -0.58 % |
Thirumeni Thiruselvaraja . | 0.084 | 0.082 | 2.33 | 1.81 | -0.52 % |
S I Dinesh Kumar . | 0.070 | 0.070 | 1.93 | 1.54 | -0.39 % |
V Agathiyan . | 0.067 | 0.065 | 1.85 | 1.43 | -0.42 % |
G Swaminathan . faced a downturn in stakeholding this quarter, witnessing a decline of -2.32 % in stakeholding compared to the previous quarter.Sayee Sundar Kasiraman faced a downturn in stakeholding this quarter, witnessing a decline of -1.47 % in stakeholding compared to the previous quarter.I Umasundari . faced a downturn in stakeholding this quarter, witnessing a decline of -1.17 % in stakeholding compared to the previous quarter.S Indirakumar . faced a downturn in stakeholding this quarter, witnessing a decline of -1.17 % in stakeholding compared to the previous quarter.Jothi Ramesh . faced a downturn in stakeholding this quarter, witnessing a decline of -0.58 % in stakeholding compared to the previous quarter.M Ramesh . faced a downturn in stakeholding this quarter, witnessing a decline of -0.58 % in stakeholding compared to the previous quarter.Thirumeni Thiruselvaraja . faced a downturn in stakeholding this quarter, witnessing a decline of -0.52 % in stakeholding compared to the previous quarter.S I Dinesh Kumar . faced a downturn in stakeholding this quarter, witnessing a decline of -0.39 % in stakeholding compared to the previous quarter.V Agathiyan . faced a downturn in stakeholding this quarter, witnessing a decline of -0.42 % in stakeholding compared to the previous quarter.
Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
---|---|---|---|---|---|
Directors and their relatives (excluding independent directors and nominee directors) | 0.017 | 0.016 | 0.46 | 0.36 | -0.1 % |
Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 0.583 | 0.626 | 16.07 | 13.75 | -2.32 % |
Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs | 1.026 | 1.361 | 28.26 | 29.88 | + 1.62 % |
Sridhar Muthuraman | 0 | 0.100 | 0 | 2.2 | +2.2% |
S Prakash | 0.078 | 0.078 | 2.14 | 1.71 | -0.43 % |
R Raja . | 0.108 | 0.108 | 2.98 | 2.37 | -0.61 % |
Malarvannan Subashini | 0.106 | 0.106 | 2.92 | 2.33 | -0.59 % |
Geetha Kannan | 0 | 0.050 | 0 | 1.1 | +1.1% |
Ajitkumar C Patel | 0.110 | 0.130 | 3.03 | 2.85 | -0.18 % |
Non Resident Indians (NRIs) | 0.015 | 0.477 | 0.41 | 10.48 | + 10.07 % |
Jayaseelan Singaravelu | 0 | 0.462 | 0 | 10.14 | +10.14% |
Bodies Corporate | 0.087 | 0.145 | 2.39 | 3.18 | + 0.79 % |
Any Other (specify) | 0.066 | 0.095 | 1.81 | 2.08 | + 0.27 % |
HUF | 0.048 | 0.071 | 1.33 | 1.57 | + 0.24 % |
LLP | 0.005 | 0.011 | 0.13 | 0.23 | + 0.1 % |
Trusts | 0.013 | 0.013 | 0.34 | 0.27 | -0.07 % |
Sridhar | 0.100 | 0 | 2.76 | 0 | -2.76% |
Observations show a significant difference of -0.1 % in Directors and their relatives (excluding independent directors and nominee directors)’s financial performance between quarters.Observations show a significant difference of -2.32 % in Resident Individuals holding nominal share capital up to Rs. 2 lakhs’s financial performance between quarters.Leading the way to higher stakeholding, Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs has significantly boosted stakeholding by an impressive 1.62 %.Observations show a significant difference of -0.43 % in S Prakash’s financial performance between quarters.Observations show a significant difference of -0.61 % in R Raja .’s financial performance between quarters.Observations show a significant difference of -0.59 % in Malarvannan Subashini’s financial performance between quarters.Observations show a significant difference of -0.18 % in Ajitkumar C Patel’s financial performance between quarters.Leading the way to higher stakeholding, Non Resident Indians (NRIs) has significantly boosted stakeholding by an impressive 10.07 %.Leading the way to higher stakeholding, Bodies Corporate has significantly boosted stakeholding by an impressive 0.79 %.Leading the way to higher stakeholding, Any Other (specify) has significantly boosted stakeholding by an impressive 0.27 %.Leading the way to higher stakeholding, HUF has significantly boosted stakeholding by an impressive 0.24 %.Leading the way to higher stakeholding, LLP has significantly boosted stakeholding by an impressive 0.1 %.Observations show a significant difference of -0.07 % in Trusts’s financial performance between quarters.Sridhar Muthuraman had no shares in the previous quarter but now holds 2.2% of shares in the current quarter.Geetha Kannan had no shares in the previous quarter but now holds 1.1% of shares in the current quarter.Jayaseelan Singaravelu had no shares in the previous quarter but now holds 10.14% of shares in the current quarter.Sridhar had 2.76% of shares in the previous quarter but exited in the current quarter.
Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
---|---|---|---|---|---|
NBFCs registered with RBI | 0 | 0.124 | 0 | 2.73 | +2.73% |
Rajasthan Global Securities Private Limited | 0 | 0.124 | 0 | 2.73 | +2.73% |
Other Financial Institutions | 0.307 | 0.185 | 8.47 | 4.07 | -4.4 % |
Next Orbit Ventures Fund | 0.307 | 0.185 | 8.47 | 4.07 | -4.4 % |
Other Financial Institutions decreased their stake from 4.07% in the previous quarter to 8.47% in the current quarter.It describes a decrease in stakes over consecutive quarters, specifically by -4.4 %.Next Orbit Ventures Fund decreased their stake from 4.07% in the previous quarter to 8.47% in the current quarter.It describes a decrease in stakes over consecutive quarters, specifically by -4.4 %.NBFCs registered with RBI had no shares in the previous quarter but now holds 2.73% of shares in the current quarter.Rajasthan Global Securities Private Limited had no shares in the previous quarter but now holds 2.73% of shares in the current quarter.
[my_shortcode1 values=”Indrayani Biotech “]